European Journal of Cancer
Volume 37, Issue 14 , Pages 1775-1780, September 2001

Early withdrawal from cervical cancer screening: the question of cost-effectiveness

  • Z Philips

      Affiliations

    • Health Economics Unit, Trent Institute for Health Services Research, University of Nottingham, Nottingham, UK
  • ,
  • D.K Whynes

      Affiliations

    • School of Economics, University of Nottingham, Nottingham NG7 2RD, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44-115-951-5463; fax: +44-115-951-4159

Received 24 April 2001; accepted 25 May 2001.

Abstract 

In countries such as the UK, mass population screening for cervical cancer has been undertaken since the 1960s. Although of established effectiveness, no formal evaluation of the screening protocol was carried out prior to its implementation. On the basis of a published mathematical modelling exercise, it has been speculated that withdrawing women from the screening programme at an earlier age than at present, whilst leading to a higher rate of invasive cervical cancer (ICC), could reduce resource use. Using estimates of screening and treatment costs, and of expected life-years lost following earlier withdrawal, we simulated cost-effectiveness ratios for various scenarios described by the model. Median cost savings resulting from a life-year lost never exceeded £10 000 for any scenario, although the estimates were particularly sensitive to the assumed age at cancer presentation and the rate of cancer progression. Our findings seem to offer little economic support for the early withdrawal of subjects from the cervical screening programme.

Keywords:  Cervical cancer, Cost-effectiveness, Mathematical model, Screening, Simulation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0959-8049(01)00199-X

European Journal of Cancer
Volume 37, Issue 14 , Pages 1775-1780, September 2001